Recall report: Another drugmaker is pulling its version of metformin off shelves after a carcinogen scare
Yet another company has voluntarily recalled lots of generic metformin hydrochloride, marking the ninth recall since the start of the year for the Type 2 diabetes drug.
Viona Pharmaceuticals has issued a recall for two lots of its 750 mg extended-release tablets, the FDA said. The product was recalled after there were levels of nitrosodimethylamine — NDMA for short — above the acceptable daily limit. NDMA has cancer-causing potential, and is sometimes found in meats, dairy products and vegetables.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
